Overview
Discounted cash flow
Income / accounting-based
Multiples & assets
Scenario
Toolbox
Weighted blend
$136.75
-18.43% vs spot
Underweight
Spot price
$167.65
Mkt cap $9.8B
subtle cardAnalyst PT consensus
$222.33
+32.62% vs spot
subtle cardMethods covered
4 / 4
4 in blend
subtle cardFootball field
ENSG · fair-value range by method
Method comparison
ENSG · fair value by valuation framework
| Method | Category | Fair value | Range | vs spot | Weight | Driver | Conf. |
|---|---|---|---|---|---|---|---|
| P/E · sector | multiple | $128.48 | $113.06 – $143.90 | -23.36% | 85.7% | EPS 5.84 × peer P/E 22.0 | med |
| PEG-anchored | multiple | $171.81 | $146.03 – $197.58 | +2.48% | 7.1% | PEG=1, fwd EPS g 29.4% | med |
| Graham revised | intrinsic | $279.43 | $237.52 – $321.34 | +66.67% | 3.6% | EPS×(8.5+2g)·4.4/Y | low |
| Lynch P/E=g | intrinsic | $122.46 | $104.09 – $140.83 | -26.95% | 3.6% | PE = g (21.0) | low |
Cost-of-capital build-up
CAPM cost of equity, after-tax cost of debt, WACC. Risk-free as of 2026-05-12.
| Risk-free rate (US 10y Treasury)rf | 4.46% |
| Equity beta (0.73)β | × 0.73 |
| Equity risk premiumERP | 4.46% |
| Cost of equity (CAPM)kₑ | 7.73% |
| Pre-tax cost of debtkd | 0.19% |
| Effective tax ratet | 23.9% |
| After-tax cost of debt | 0.15% |
| Equity weight$2.2B | 35.0% |
| Debt weight$4.2B | 65.0% |
| WACC | 2.80% |
Growth assumptions
Blended forward growth used as DCF default; terminal pegged to long-run nominal GDP.
| Analyst forward revenue growthFMP | 15.32% |
| Analyst forward EPS growthFMP | 29.42% |
| Historical 5y revenue CAGRFY | 17.79% |
| Historical 5y EPS CAGRFY | 14.31% |
| Sustainable g (ROE × retention)Δ | 14.75% |
| Blended near-term growth (g₀) | 20.97% |
| Terminal growth (gₗ) | 2.30% |
Sources
- FMP /analyst-estimates— 8 rows(as of 2021-12-30)
- Treasury rates · 10y— 4.46% rf(as of 2026-05-12)
- market_risk_premium · DB— 4.46% ERP(as of 2026-05-13)
- Sector multiple defaults— Healthcare (live sector PE unavailable)
- FMP /price-target-consensus— mean $222.33
This page is generated by a quantitative valuation engine for research purposes only and does not constitute investment advice. Methodology follows standard CFA / Damodaran frameworks; assumptions are driven by analyst consensus from Financial Modeling Prep and reported financial statements.